Alinger Pharmaceutical Private Limited

Alinger Pharmaceutical Private Limited - pharma in Makarba, Gujarat, India. FY 2026 financials & compliance.
CIN U74999GJ2019PTC106453 Incorporated 06 February 2019 ROC Ahmedabad HQ Makarba, Gujarat, India
Active Private Limited Company pharma MSME · Micro
Revenue · FY 2025
₹1.25 Cr
▲ 18% YoY
Net profit · FY 2025
₹72,251
Net margin 0.6%
EBITDA · FY 2025
₹2.03 Lakh
EBITDA margin 1.6%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹14 Lakh
Satisfied ₹4 Lakh
Company age
7 yrs
Est. 2019
Directors on board
2
As per MCA filings

About Alinger Pharmaceutical Private Limited

Data last updated:

Alinger Pharmaceutical Private Limited is a private limited company based in Makarba, Gujarat, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 06 February 2019 and has been in existence for over 7 years.

The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U74999GJ2019PTC106453. Its GSTIN is 08AARCA8945Q1ZI (Rajasthan).

The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Vinod Kumar Sharma and Pinky Sharma.

Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Office No. A/1107 Siddhi Vinayak Tower – A B/Hdcp Office Off Sg Highway Sur No212/2, Makarba, Gujarat, India – 380051.

As per the financials filed for FY 2025, the company reported a revenue of ₹1.25 Cr, a growth of 18% compared to the previous year. For the same year it recorded a net profit of ₹72,251 (net margin 0.6%) and EBITDA of ₹2.03 Lakh (EBITDA margin 1.6%). Revenue has grown at a compounded annual rate (CAGR) of 45% over three years and 48% over five years.

As per MCA filings, the company has open charges of ₹14 Lakh and satisfied charges of ₹4 Lakh on record.

Alinger Pharmaceutical Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-RJ-17-0120339). The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U74999GJ2019PTC106453
Registration Number 106453
Incorporation Date 06 February 2019
ROC Ahmedabad
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-RJ-17-0120339

Recognitions & Rankings of Alinger Pharmaceutical

MSME (Udyam registered) Ministry of MSME
Category
Micro (2023-24)
Udyam number
UDYAM-RJ-17-0120339

Contact details

Alinger Pharmaceutical Private Limited's registered office is in Makarba, Gujarat. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    Office No. A/1107 Siddhi Vinayak Tower – A B/Hdcp Office Off Sg Highway Sur No212/2, Makarba, Gujarat, India – 380051
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors

To see the full contact details of Alinger Pharmaceutical Private Limited, buy the company report.

Comprehensive company report
Alinger Pharmaceutical Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Alinger Pharmaceutical is trade. In detail, this covers wholesale trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG1Wholesale Trading

To see the full business activity and turnover split of Alinger Pharmaceutical Private Limited, buy the company report.

Financials of Alinger Pharmaceutical Private Limited

FY 2025 filings available

Alinger Pharmaceutical Private Limited reported revenue of ₹1.25 Cr (up 18% YoY) for FY 2025.

Revenue · FY 2025
₹1.25 Cr ▲ 18%
Net profit · FY 2025
₹72,251 margin 0.6%
EBITDA · FY 2025
₹2.03 Lakh margin 1.6%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 18%
3 years · compounded
▲ 45%
5 years · compounded
▲ 48%
EBITDA CAGR growth
1 year
▲ 44%
3 years · compounded
▲ 102%
5 years · compounded
▲ 128%

Revenue has grown at a compounded annual rate (CAGR) of 48% over five years, including 18% growth in the latest year. EBITDA rose 44% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹2.03 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹72,251
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin1.6%
Net Profit Margin0.6%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Alinger Pharmaceutical Private Limited, buy the company report.

Board of directors of Alinger Pharmaceutical Private Limited

Alinger Pharmaceutical has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Vinod Kumar SharmaDirector27 May 20206 Years 5 MonthsCurrent
Pinky SharmaDirector06 Feb 20197 Years 9 MonthsCurrent

Peer comparison

Alinger Pharmaceutical Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trading), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Amit Metchem Private Limited₹1.25 Cr (FY 2025)188.0%Kolkata, West Bengal, India
Rishaal Industries Private Limited₹1.25 Cr (FY 2025)-70.0%Sonipat, Haryana, India
Pinky Promise Private Limited₹1.25 Cr (FY 2024)3796.0%Mumbai, Maharashtra, India
Eirotech Industries Private Limited₹1.25 Cr (FY 2016)-48.0%New Delhi, Delhi, India
Zorin Projects Private Limited₹1.25 Cr (FY 2024)-54.0%Hazaribag, Jharkhand, India
Alinger Pharmaceutical Private Limitedthis company₹1.25 Cr (FY 2025)₹72,2510.6%18.0%Makarba, Gujarat, India
Parable Ventures Private Limited₹1.25 Cr (FY 2025)227.0%Delhi, India
Uvalianza Ventures Private Limited₹1.25 Cr (FY 2024)-19.0%Pune, Maharashtra, India
Shubhanker Engineers Private Limited₹1.25 Cr (FY 2024)66.0%Jaipur, Rajasthan, India
Noviara Chemicals Private Limited₹1.25 Cr (FY 2024)-3.0%Ernakulam, Kerala, India
P S K Popular Trading Private Limited₹1.25 Cr (FY 2022)39.0%Erode, Tamil Nadu, India

To see the full peer comparison of Alinger Pharmaceutical Private Limited, buy the company report.

Auditor

Alinger Pharmaceutical Private Limited is audited by MANISH JAIN & CO for the financial year 2019.

Auditor firmFinancial yearFirm registration number
MANISH JAIN & COFY 2019019522C

Shareholding

The shareholding of Alinger Pharmaceutical Private Limited is on record for FY 2019, split between promoters, domestic institutions, public shareholders and others.

Shareholder categoryFY 2019
Promoters
Domestic institutional investors (DII)
Public
Others

To see the full shareholding pattern of Alinger Pharmaceutical Private Limited, buy the company report.

Charges & borrowings

Open charges
₹14 Lakh
Satisfied charges
₹4 Lakh
Breakdown by lending institutions
State Bank of India₹0.14 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
16 May 2022100582958State Bank of India₹14 LakhOpen
15 Oct 2019100299588Axis Bank Limited₹4 LakhSatisfied

To see the full charge records of Alinger Pharmaceutical Private Limited, buy the company report.

Total charge records: 2 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Alinger Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Alinger Pharmaceutical has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
08AARCA8945Q1ZIRajasthanActive26 Mar 2019

To see the full GST registrations and return filing status of Alinger Pharmaceutical Private Limited, buy the company report.

Recent activity

Alinger Pharmaceutical Private Limited has 3 board changes on record since 2019: 2 appointments and 1 cessation. The latest: Mithlesh Kumari ceased to be Director on 27 May 2020.

AGM
Alinger Pharmaceutical Private Limited last Annual general meeting of members was held on 29 Sep 2025 as per latest MCA records.
Charges
A charge with State Bank Of India of Rs. 14.00 Lakh registered on 16 May 2022 with Charge ID 100582958 was modified on 06 Jun 2025.
Filing
Alinger Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad.
Charges
A charge with State Bank Of India amounted to Rs. 14.00 Lakh with Charge ID 100582958 was registered on 16 May 2022.
Charges
A charge registered on 15 Oct 2019 via Charge ID 100299588 with Axis Bank Limited was fully satisfied on 17 Jul 2021.
Ceased
Mithlesh Kumari ceased to be Director.
Appointed
Vinod Kumar Sharma was appointed as Director.
Charges
A charge with Axis Bank Limited amounted to Rs. 4.00 Lakh with Charge ID 100299588 was registered on 15 Oct 2019.
Appointed
Pinky Sharma was appointed as Director.
Incorporation
06 Feb 2019
Alinger Pharmaceutical Private Limited was registered on 06 Feb 2019 with Roc Ahmedabad & aged 7 years 9 months as per MCA records.

Frequently asked questions

Alinger Pharmaceutical is an active private limited company based in Makarba, Gujarat, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 06 February 2019 (7+ years old) and is registered under CIN U74999GJ2019PTC106453.

Alinger Pharmaceutical has 2 current directors:

The latest financial statements of Alinger Pharmaceutical on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 29 September 2025. Year-wise statements from FY 2019 are in the company report.

The GSTIN of Alinger Pharmaceutical is 08AARCA8945Q1ZI, registered in Rajasthan.

The CIN (Corporate Identification Number) of Alinger Pharmaceutical is U74999GJ2019PTC106453. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Alinger Pharmaceutical was incorporated on 06 February 2019, making it 7+ years old. It is registered with the Registrar of Companies, Ahmedabad.

The peers of Alinger Pharmaceutical by revenue are Amit Metchem Private Limited, Rishaal Industries Private Limited, Pinky Promise Private Limited, Eirotech Industries Private Limited, Zorin Projects Private Limited and 5 more, all in the same principal business activity (wholesale trading).

Mithlesh Kumari ceased to be Director on 27 May 2020. Vinod Kumar Sharma was appointed as Director on 27 May 2020. Pinky Sharma was appointed as Director on 06 Feb 2019.

Yes, Alinger Pharmaceutical is registered as a micro enterprise under Udyam registration (number: UDYAM-RJ-17-0120339).

The registered office of Alinger Pharmaceutical is at Office No. A1107 Siddhi Vinayak Tower – A BHdcp Office Off Sg Highway Sur No2122, Makarba, Gujarat, India – 380051.

Alinger Pharmaceutical operates in the pharma industry, in the pharmaceutical retailers and distributors segment.